Good News | Our Company Successfully Passes PSCI Audit and Gains Recognition in the Novartis Partner System, Demonstrating Compliance and Responsibility

Recently, our company successfully passed a specialized audit conducted by PSCI (Pharmaceutical Supply Chain Initiative), a globally leading organization in responsible business practices, officially joining the ranks of qualified suppliers recognized by the Novartis partner system. This achievement is not only an authoritative certification of our company’s comprehensive operational capabilities in quality management, supply chain compliance, and social responsibility, but also a strong endorsement from the industry and our partners of our professional strength.

Since the preparation for the audit, our company has consistently adhered to the rigorous standards of PSCI, comprehensively reviewing and optimizing management systems and execution details across all aspects, from production processes and quality control to employee rights protection and environmental management. By establishing a standardized full-process operational system and strengthening risk anticipation and control mechanisms, we ensured that every task complies with internationally leading industry standards. Ultimately, with a solid management foundation and rigorous execution, we successfully passed this audit.

As a leading global company in the pharmaceutical and healthcare field, Novartis maintains very high standards in selecting its partners, and the PSCI audit serves as a key benchmark for measuring a supplier’s overall strength and sense of responsibility. Successfully passing this audit signifies that our company now meets the core requirements of international cooperation in compliant operations, quality assurance, and sustainable development, laying a solid foundation for deep cooperation in the healthcare sector in the future.

Going forward, we will take this audit success as a new starting point to continuously deepen our implementation of advanced international standards, steadily enhancing our core competitiveness and sustainability. At the same time, we will cherish the opportunity to collaborate with leading industry partners like Novartis, providing the industry with higher quality products and services, jointly creating more valuable cooperative outcomes, and contributing to the high-quality development of the industry!